Cargando…

Increased lanosterol turnover: a metabolic burden for daunorubicin-resistant leukemia cells

The cholesterol metabolism is essential for cancer cell proliferation. We found the expression of genes involved in the cholesterol biosynthesis pathway up-regulated in the daunorubicin-resistant leukemia cell line CEM/R2, which is a daughter cell line to the leukemia cell line CCRF-CEM (CEM). Cellu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stäubert, Claudia, Krakowsky, Rosanna, Bhuiyan, Hasanuzzaman, Witek, Barbara, Lindahl, Anna, Broom, Oliver, Nordström, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2015
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689760/ https://www.ncbi.nlm.nih.gov/pubmed/26698156 http://dx.doi.org/10.1007/s12032-015-0717-5

Ejemplares similares

Hydroxycarboxylic acid receptors are essential for breast cancer cells to control their lipid/fatty acid metabolism
por: Stäubert, Claudia, et al.
Publicado: (2015)

Effect of lanosterol on human cataract nucleus
por: Shanmugam, P Mahesh, et al.
Publicado: (2015)

Comment to: Effect of lanosterol on human nuclei
por: Venkatesh, Ramesh, et al.
Publicado: (2016)

Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil.
por: Sehested, M., et al.
Publicado: (1987)

Evolutionary analyses reveal immune cell receptor GPR84 as a conserved receptor for bacteria-derived molecules
por: Schulze, Amadeus Samuel, et al.
Publicado: (2022)

Failure of Oxysterols Such as Lanosterol to Restore Lens Clarity from Cataracts
por: Daszynski, Damian M., et al.
Publicado: (2019)

Combination of bortezomib and daunorubicin in the induction of apoptosis in T-cell acute lymphoblastic leukemia
por: Du, Xin, et al.
Publicado: (2017)

CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
por: Lancet, Jeffrey E., et al.
Publicado: (2018)

Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience
por: Tefferi, Ayalew, et al.
Publicado: (2022)

Adipocytes cause leukemia cell resistance to daunorubicin via oxidative stress response
por: Sheng, Xia, et al.
Publicado: (2016)

Self-Assembled Daunorubicin/Epigallocatechin Gallate Nanocomplex for Synergistic Reversal of Chemoresistance in Leukemia
por: Bae, Ki Hyun, et al.
Publicado: (2022)

Adipocyte metabolism of the chemotherapy daunorubicin
por: Mittelman, Steven D., et al.
Publicado: (2018)

Combining metabolic phenotype determination with metabolomics and transcriptional analyses to reveal pathways regulated by hydroxycarboxylic acid receptor 2
por: Rabe, Philipp, et al.
Publicado: (2022)

Lanosterol Synthase Pathway Alleviates Lens Opacity in Age-Related Cortical Cataract
por: Shen, Xinyue, et al.
Publicado: (2018)

Platelet Microparticles Protect Acute Myelogenous Leukemia Cells against Daunorubicin-Induced Apoptosis
por: Cacic, Daniel, et al.
Publicado: (2021)

Casein-Based Nanoparticles: A Potential Tool for the Delivery of Daunorubicin in Acute Lymphocytic Leukemia
por: Zahariev, Nikolay, et al.
Publicado: (2023)

Cytochrome P450 metabolism of the post-lanosterol intermediates explains enigmas of cholesterol synthesis
por: Ačimovič, Jure, et al.
Publicado: (2016)

The Oxidosqualene Cyclase from the Oomycete Saprolegnia parasitica Synthesizes Lanosterol as a Single Product
por: Dahlin, Paul, et al.
Publicado: (2016)

Structural and Functional Elucidation of Yeast Lanosterol 14α-Demethylase in Complex with Agrochemical Antifungals
por: Tyndall, Joel D. A., et al.
Publicado: (2016)

Azole sensitivity in Leptosphaeria pathogens of oilseed rape: the role of lanosterol 14α-demethylase
por: Sewell, Thomas R., et al.
Publicado: (2017)

Triterpenoid modulates the salt tolerance of lanosterol synthase deficient Saccharomyces cerevisiae, GIL77
por: Inafuku, Masashi, et al.
Publicado: (2018)

Protective Effects of Lanosterol Synthase Up-Regulation in UV-B-Induced Oxidative Stress
por: Hua, Hui, et al.
Publicado: (2019)

Combination of Lanosterol and Nilvadipine Nanosuspensions Rescues Lens Opacification in Selenite-Induced Cataractic Rats
por: Deguchi, Saori, et al.
Publicado: (2022)

Liposomal daunorubicin as treatment for Kaposi’s sarcoma
por: Petre, Christin E, et al.
Publicado: (2007)

Interactions of Cisplatin and Daunorubicin at the Chromatin Level
por: Firouzi Niaki, Erfaneh, et al.
Publicado: (2020)

Downregulating CREBBP inhibits proliferation and cell cycle progression and induces daunorubicin resistance in leukemia cells
por: Gao, Chao, et al.
Publicado: (2020)

Resistance Mechanism of Acute Myeloid Leukemia Cells Against Daunorubicin and Cytarabine: A Literature Review
por: Arwanih, Elly Y, et al.
Publicado: (2022)

Probes for protein adduction in cholesterol biosynthesis disorders: Alkynyl lanosterol as a viable sterol precursor
por: Tallman, Keri A., et al.
Publicado: (2017)

Marine Benthic Cyanobacteria Contain Apoptosis-Inducing Activity Synergizing with Daunorubicin to Kill Leukemia Cells, but not Cardiomyocytes
por: Oftedal, Linn, et al.
Publicado: (2010)

Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid Leukemia and Enhances Chemosensitivity to Daunorubicin
por: Han, Yixiang, et al.
Publicado: (2015)

Targeting Notch-1 positive acute leukemia cells by novel fucose-bound liposomes carrying daunorubicin
por: Ono, Michihiro, et al.
Publicado: (2016)

Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML
por: Chen, Evan C, et al.
Publicado: (2018)

Risk Factors of Daunorubicine Induced Early Cardiotoxicity in Childhood Acute Lymphoblastic Leukemia: A Retrospective Study
por: Samosir, Sunny Mariana, et al.
Publicado: (2021)

Anti-CD123 antibody-modified niosomes for targeted delivery of daunorubicin against acute myeloid leukemia
por: Liu, Fu-rong, et al.
Publicado: (2017)

Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan
por: Ikezoe, Takayuki, et al.
Publicado: (2022)

An Erg11 lanosterol 14-α-demethylase-Arv1 complex is required for Candida albicans virulence
por: Villasmil, Michelle L., et al.
Publicado: (2020)

The Intravitreal Injection of Lanosterol Nanoparticles Rescues Lens Structure Collapse at an Early Stage in Shumiya Cataract Rats
por: Nagai, Noriaki, et al.
Publicado: (2020)

Inhibitory effect of lanosterol on cataractous lens of cynomolgus monkeys using a subconjunctival drug release system
por: Zhang, Keke, et al.
Publicado: (2022)

HMGA2 regulates acute myeloid leukemia progression and sensitivity to daunorubicin via Wnt/β-catenin signaling
por: Yang, Shuo, et al.
Publicado: (2019)

TRIM31 promotes acute myeloid leukemia progression and sensitivity to daunorubicin through the Wnt/β-catenin signaling
por: Xiao, Yi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ah8fk1u5gid5ar6qkbmusnuial